Pacific Edge Named In Deloitte Fast 50 Awards

Pacific Edge has once again been named in the Deloitte Fast 50 Awards, as it continues to execute on its commercial strategy and drive revenue growth.

Pacific Edge was named 48th in the Fast 50 Index and the fastest growing export business for Dunedin and Lower South Island.

The company, which has recently completed a highly successful and well supported capital raise, is now well positioned to accelerate its growth, with recent commercial milestones, clinical validation and the increasing adoption of its Cxbladder products all in its favour.

CEO David Darling said: “We are delighted to again be included in the Deloitte Fast 50 index. This is further recognition of the hard work and effort that has been put in by our global team and the resulting successes over the last 18-months bringing our company to this stage of our growth journey.

“The most exciting part of our journey is now underway with the traction we are getting in the United States, the world’s largest healthcare market. We are poised for further growth with more urologists and large scale healthcare organisations recognising the value of our Cxbladder diagnostic products and adopting them for use in their clinical settings.”

The Deloitte Fast 50 celebrated its 21st year in 2021 recognising New Zealand’s fastest growing companies across the Fast 50 and Master of Growth indices. The Fast 50 index recognises businesses that have shown significant growth over the last three years. The index is determined by revenue growth percentage.